The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT01270191
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Registry
-
NCT01270191
-
- Other papers using this trial's data
- Effects of insulin and exenatide therapy on glycemic control and β-cell function in patients newly diagnosed with type 2 diabetes and severe hyperglycemia
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT01270191. Randomized; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Exenatide
- Intervention (Drug)
- Humulin-N
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
Record details
- Record id
cardio:ct-nct01270191- Content hash
a7f1478d6330da3881b35be1bedb7774d5914c487574cb125cb68ef5b209a0e5